Drugs for Treating Mental Disorders Market

Drugs for Treating Mental Disorders Market contains market size and forecasts of Drugs for Treating Mental Disorders in Global, including the following market information:

Global Drugs for Treating Mental Disorders Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Drugs for Treating Mental Disorders market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Tablets Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Drugs for Treating Mental Disorders include Johnson and Johnson, Pfizer, Eli Lilly, GlaxoSmithKline, AstraZeneca, Bristol-Myers Squibb, Teva Pharmaceutical, Dr. Reddy's Laboratories and Apotex Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Drugs for Treating Mental Disorders companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Drugs for Treating Mental Disorders Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Drugs for Treating Mental Disorders Market Segment Percentages, by Type, 2021 (%)

Tablets

Capsule

Injection

Solution

Other

Global Drugs for Treating Mental Disorders Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Drugs for Treating Mental Disorders Market Segment Percentages, by Application, 2021 (%)

Antipsychotics

Antidepressants

Antianxiety (Anxiolyitcs)

Anti-Seizure Medications

Stimulants

Cognitive Disorders And Dementia

Sleep Disorder Treatments

Substance Abuse Treatments

Hypnosis And Tranquilizers

Other

Global Drugs for Treating Mental Disorders Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Drugs for Treating Mental Disorders Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Drugs for Treating Mental Disorders revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Drugs for Treating Mental Disorders revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Johnson and Johnson

Pfizer

Eli Lilly

GlaxoSmithKline

AstraZeneca

Bristol-Myers Squibb

Teva Pharmaceutical

Dr. Reddy's Laboratories

Apotex Inc.

Mylan Pharmaceuticals

Par Pharmaceutical

Aurobindo Pharma

Torrent Pharmaceuticals

Jubilant Lifesciences

Sun Pharmaceutical

Sandoz (Novartis)

Hansoh Pharmaceutical

WATSON Pharmaceuticals

Zhejiang Langhua Pharmaceuticals

Forest Laboratories

H.Lundbeck A/S

Amneal Pharmaceuticals

Hetero Drugs

Macleods Pharmaceuticals

Silarx Pharmacueticals

Hikma Pharmaceuticals

Lupin Limited

Prinston Pharmaceutical

STI Pharma